|
Treatment Strategies - Salvage Therapy
Treatment Strategies - Salvage Therapy
(Also called "Rescue Therapy" or "Third-Line Therapy")
Strategies for third-line HIV therapy. Fact sheet from Project Inform. Also available in Spanish.
Salvage therapy. Fact sheet for AIDS InfoNet. Also available in Spanish.
About the HIV Treatment Guidelines. Fact sheet from AIDSinfo explaining the U.S. Department of Health and Human Services guidelines for the treatment of HIV infection in adults. Also available in Spanish.
HIV and Its Treatment: What You Should Know. Fact sheet series from AIDSinfo with an overview of HIV infection and treatment beneficial for individuals recently diagnosed with HIV infection or who are considering starting HIV treatment. Includes information on testing, medications, treatment adherence, pregnancy, and prevention. Also available in Spanish.
Antiretroviral Formulations. Chart from AIDSinfo listing all available formulations of anti-HIV drugs approved by the Food and Drug Administration for use in the United States. For each drug, there is a link to an associated fact sheet with information about that specific medication. Also available in Spanish.
Approved Medications to Treat HIV Infection. Fact sheet from AIDSinfo with a list of medications used to treat HIV infection, including generic and brand names and date approved by the Food and Drug Administration for use in the United States. For each drug, there is a link to an associated fact sheet with information about that specific medication. Also available in Spanish.
Is my treatment regimen working? Fact sheet from AIDSinfo website.
HIV treatment regimen failure. Fact sheet from AIDSinfo website.
Changing my HIV treatment regimen. Fact sheet from AIDSinfo website.
Salvage therapies. Web page with links to many articles on the hivandhepatitis.com website.
Third line/rescue HIV treatment. Web page with links to fact sheets and articles on thebody.com website.
Selected Recent Articles
Multiple treatment failures occur less frequently but remain associated with high mortality rates in North American cohort. Article dated November 6, 2009 from aidsmap.com.
Darunavir/ritonavir, etravirine and raltegravir combination has 'remarkable' success in children with resistant virus. Article dated October 30, 2009 from aidsmap.com.
Etravirine, darunavir/ritonavir and raltegravir very effective in highly treatment-experienced patients. Article dated October 19, 2009 from aidsmap.com.
Isentress Without a Protease Inhibitor Is Effective for Treatment Experienced Patients. Article dated July 31, 2009 from aidsmeds.com.
Triple-Drug Regimen Works Well for Heavily Treatment-Experienced Patients. Article dated July 22, 2009 from aidsmeds.com.
Treatment Adherence: Still Important. Article dated March 24, 2009 from aidsmeds.com.
News Briefs. Article from the Winter/Spring 2009 issue of BETA. Search for section titled "Combining new drugs."
Treatment Adherence: Better Is Best. Article dated December 16, 2008 from aidsmeds.com.
Second-line combinations fail twice as often as first-line ones in the first year. Article dated November 16, 2008 from aidsmap.com.
If you can't switch, better to stay on failing treatment than stop it, studies show. Article dated November 14, 2008 from aidsmeds.com.
Changing the HIV Treatment Paradigm. Article dated November 4, 2008 from aidsmeds.com.
Major Updates to DHHS HIV Treatment Guidelines. Article dated November 3, 2008 from aidsmeds.com.
CD4 decline, death more likely if change from NNRTI regimen delayed. Article dated October 23, 2008 from aidsmap.com.
Higher levels of drug resistance seen after first-line NNRTI failure than boosted PI failure: meta-analysis. Articled dated October 3, 2008 from aidsmap.com.
Future Options for the Treatment Experienced. Article dated September 24, 2008 from aidsmeds.com.
Uptake of second-line treatment `stagnant` in developing world. Article dated August 14, 2008 from aidsmap.com.
Getting the Most from Available Antiretroviral Therapies. Article from the Summer 2008 issue of BETA.
Low rate of toxicity-related treatment change suggests HIV treatment tolerable in the long-term. Article dated May 29, 2008 from aidsmap.com.
Clinical monitoring as effective as CD4 count and viral load for deciding when to switch to second-line ART in poor countries. Article dated April 25, 2008 from aidsmap.com.
Treatment Failure: Symptoms Matter Too. Article dated April 25, 2008 from aidsmeds.com.
Combined Resistance Analysis Better Predicts Treatment Failures. Article dated April 7, 2008 from aidsmeds.com.
Even Failing Treatment Reduces HIV in the Brain. Article dated April 2, 2008 from aidsmeds.com.
CROI 2008: Transcript: New Hope for Treatment Experienced. Article dated February 26, 2008 from aidsmeds.com.
CROI: Risk of second virological failure has declined since 1996, but risk of death remains stable. Article dated February 7, 2008 from aidsmap.com.
Drug level monitoring nearly doubles likelihood of reaching target levels. Article dated December 17, 2007 from aidsmap.com.
Triple-Class Drug Failure Uncommon After 10 Years of HAART Use. Article dated December 12, 2007 from aidsmeds.com.
Triple-class failure emerges slowly in UK patients. Article dated December 7, 2007 from aidsmap.com.
New menu of antiviral options. Article dated November 13, 2007 from the aidsmeds.com website.
Undetectable viral load is goal for all, together with earlier treatment, say new European treatment guidelines. Article dated October 25, 2007 from the aidsmap.com website.
|
